HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches (Q33760273)

29 July 2017

1 reference

title

HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches (English)

1 reference

29 July 2017

0 references

Watson K

1 reference

29 July 2017

Edwards RJ

series ordinal

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

published in

Biochemical Pharmacology

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

1521-1528

1 reference

The molecular biology of human immunodeficiency virus type 1 infection

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The biochemistry of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The regulation of human immunodeficiency virus type-1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

HIV-1 tat trans-activation requires the loop sequence within tar.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Cellular uptake of the tat protein from human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Human Immunodeficiency Virus Type 1 TAT Protein Activates B Lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Angiogenic properties of human immunodeficiency virus type 1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A dual receptor system is required for basic fibroblast growth factor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Disseminated Kaposi's sarcoma in homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

An AIDS-like condition induced in baboons by HIV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Anti-HIV synergism between dextran sulphate and zidovudine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A lipidated anti-Tat antibody enters living cells and blocks HIV-1 viral replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Structural studies of HIV-1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Tat-mediated delivery of heterologous proteins into cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Caspases: Intracellular Signaling by Proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

ICE family proteases: mediators of all apoptotic cell death?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Caspases: the executioners of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

A review of Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900209-9

7 January 2021

10.1016/S0006-2952(99)00209-9

Identifiers

DOI

1 reference

29 July 2017

1 reference